BACKGROUND: The significance of endoscopic activity in asymptomatic ulcerative colitis (UC) patients with an ileal pouch is unknown. AIM: To investigate the association of endoscopic pouch activity in asymptomatic patients with the subsequent development of pouchitis. METHODS: We analyzed a retrospective cohort of patients with UC or IBD-unspecified who underwent a total proctocolectomy with ileal pouch anal anastomosis (IPAA). Asymptomatic patients with a Pouchitis Disease Activity Index (PDAI) symptom sub-score of zero who underwent an index surveillance pouchoscopy were included. Endoscopic pouch body activity was graded as 0: normal, 1: mucosal inflammation, or 2: mucosal breaks (ulcers and/or erosions). The primary outcome was primary acute idiopathic pouchitis defined as PDAI score ≥ 7 with symptoms lasting less than four weeks and responsive to standard antibiotics, not otherwise meeting criteria for secondary pouchitis. The secondary outcome was chronic idiopathic pouchitis defined as PDAI score ≥ 7 with symptoms lasting greater than four weeks despite standard antibiotics. Predictors of pouchitis were analyzed using Kaplan-Meier and Cox regression methods with hazard ratios (HR) and 95% confidence intervals (CI) reported. RESULTS: 143 asymptomatic pouch patients were included. Index endoscopic pouch body activity was 0 in 86 (60.1%) patients, 1 in 26 (18.2%) and 2 in 31 (21.7%). The median length of follow-up after index surveillance pouchoscopy was 3.03 [IQR 1.24-4.60] years. Primary acute idiopathic pouchitis occurred in 44 (31%) patients and chronic idiopathic pouchitis in 12 (8.4%). Grade 2 endoscopic pouch activity was associated with the development of acute pouchitis (HR 2.39, 95% CI 1.23-4.67), although not chronic pouchitis (HR 1.76, 95% CI 0.53-5.87). Histologic inflammation in endoscopically normal pouch mucosa was not associated with acute or chronic pouchitis. CONCLUSIONS: Mucosal breaks are present in nearly a quarter of asymptomatic patients with IPAA and are associated with an increased risk of acute pouchitis.
BACKGROUND: The significance of endoscopic activity in asymptomatic ulcerative colitis (UC) patients with an ileal pouch is unknown. AIM: To investigate the association of endoscopic pouch activity in asymptomatic patients with the subsequent development of pouchitis. METHODS: We analyzed a retrospective cohort of patients with UC or IBD-unspecified who underwent a total proctocolectomy with ileal pouch anal anastomosis (IPAA). Asymptomatic patients with a Pouchitis Disease Activity Index (PDAI) symptom sub-score of zero who underwent an index surveillance pouchoscopy were included. Endoscopic pouch body activity was graded as 0: normal, 1: mucosal inflammation, or 2: mucosal breaks (ulcers and/or erosions). The primary outcome was primary acute idiopathic pouchitis defined as PDAI score ≥ 7 with symptoms lasting less than four weeks and responsive to standard antibiotics, not otherwise meeting criteria for secondary pouchitis. The secondary outcome was chronic idiopathic pouchitis defined as PDAI score ≥ 7 with symptoms lasting greater than four weeks despite standard antibiotics. Predictors of pouchitis were analyzed using Kaplan-Meier and Cox regression methods with hazard ratios (HR) and 95% confidence intervals (CI) reported. RESULTS: 143 asymptomatic pouch patients were included. Index endoscopic pouch body activity was 0 in 86 (60.1%) patients, 1 in 26 (18.2%) and 2 in 31 (21.7%). The median length of follow-up after index surveillance pouchoscopy was 3.03 [IQR 1.24-4.60] years. Primary acute idiopathic pouchitis occurred in 44 (31%) patients and chronic idiopathic pouchitis in 12 (8.4%). Grade 2 endoscopic pouch activity was associated with the development of acute pouchitis (HR 2.39, 95% CI 1.23-4.67), although not chronic pouchitis (HR 1.76, 95% CI 0.53-5.87). Histologic inflammation in endoscopically normal pouch mucosa was not associated with acute or chronic pouchitis. CONCLUSIONS: Mucosal breaks are present in nearly a quarter of asymptomatic patients with IPAA and are associated with an increased risk of acute pouchitis.
Authors: Howard Ross; Scott R Steele; Mika Varma; Sharon Dykes; Robert Cima; W Donald Buie; Janice Rafferty Journal: Dis Colon Rectum Date: 2014-01 Impact factor: 4.585
Authors: Amandeep K Shergill; Jenifer R Lightdale; David H Bruining; Ruben D Acosta; Vinay Chandrasekhara; Krishnavel V Chathadi; G Anton Decker; Dayna S Early; John A Evans; Robert D Fanelli; Deborah A Fisher; Lisa Fonkalsrud; Kimberly Foley; Joo Ha Hwang; Terry L Jue; Mouen A Khashab; V Raman Muthusamy; Shabana F Pasha; John R Saltzman; Ravi Sharaf; Brooks D Cash; John M DeWitt Journal: Gastrointest Endosc Date: 2015-03-20 Impact factor: 9.427
Authors: J P Segal; N S Ding; G Worley; S Mclaughlin; S Preston; O D Faiz; S K Clark; A L Hart Journal: Aliment Pharmacol Ther Date: 2016-12-23 Impact factor: 8.171
Authors: Jean Frédéric Colombel; William J Sandborn; Walter Reinisch; Gerassimos J Mantzaris; Asher Kornbluth; Daniel Rachmilewitz; Simon Lichtiger; Geert D'Haens; Robert H Diamond; Delma L Broussard; Kezhen L Tang; C Janneke van der Woude; Paul Rutgeerts Journal: N Engl J Med Date: 2010-04-15 Impact factor: 91.245
Authors: L Peyrin-Biroulet; W Sandborn; B E Sands; W Reinisch; W Bemelman; R V Bryant; G D'Haens; I Dotan; M Dubinsky; B Feagan; G Fiorino; R Gearry; S Krishnareddy; P L Lakatos; E V Loftus; P Marteau; P Munkholm; T B Murdoch; I Ordás; R Panaccione; R H Riddell; J Ruel; D T Rubin; M Samaan; C A Siegel; M S Silverberg; J Stoker; S Schreiber; S Travis; G Van Assche; S Danese; J Panes; G Bouguen; S O'Donnell; B Pariente; S Winer; S Hanauer; J-F Colombel Journal: Am J Gastroenterol Date: 2015-08-25 Impact factor: 10.864
Authors: F Bär; T Kühbacher; N A Dietrich; T Krause; A Stallmach; N Teich; S Schreiber; J Walldorf; R Schmelz; C Büning; K Fellermann; J Büning; U Helwig Journal: Aliment Pharmacol Ther Date: 2017-12-19 Impact factor: 8.171
Authors: Mark A Samaan; Katrina Forsyth; Jonathan P Segal; Djuna De Jong; Jasper L A Vleugels; Soad Elkady; Misha Kabir; Samantha Campbell; Klaartje Kok; David G Armstrong; Lawrence Penez; Aitor P Arenaza; Edward Seward; Roser Vega; Shameer Mehta; Farooq Rahman; Sara McCartney; Stuart Bloom; Kamal Patel; Richard Pollok; Edward Westcott; Amir Darakhshan; Andrew Williams; Ioannis Koumoutsos; Shuvra Ray; Joel Mawdsley; Simon Anderson; Jeremy D Sanderson; Evelien Dekker; Geert R D'Haens; Ailsa Hart; Peter M Irving Journal: J Crohns Colitis Date: 2019-05-27 Impact factor: 9.071
Authors: Fernando Magro; Paolo Gionchetti; Rami Eliakim; Sandro Ardizzone; Alessandro Armuzzi; Manuel Barreiro-de Acosta; Johan Burisch; Krisztina B Gecse; Ailsa L Hart; Pieter Hindryckx; Cord Langner; Jimmy K Limdi; Gianluca Pellino; Edyta Zagórowicz; Tim Raine; Marcus Harbord; Florian Rieder Journal: J Crohns Colitis Date: 2017-06-01 Impact factor: 10.020
Authors: Shintaro Akiyama; Jacob E Ollech; Victoria Rai; Laura R Glick; Yangtian Yi; Cindy Traboulsi; Joseph Runde; Russell D Cohen; Kinga B Skowron; Roger D Hurst; Konstantin Umanskiy; Benjamin D Shogan; Neil H Hyman; Michele A Rubin; Sushila R Dalal; Atsushi Sakuraba; Joel Pekow; Eugene B Chang; David T Rubin Journal: Clin Gastroenterol Hepatol Date: 2021-02-05 Impact factor: 11.382
Authors: Joseph Runde; Amarachi Erondu; Shintaro Akiyama; Cindy Traboulsi; Victoria Rai; Laura R Glick; Yangtian Yi; Jacob E Ollech; Russell D Cohen; Kinga B Skowron; Roger D Hurst; Konstatin Umanskiy; Benjamin D Shogan; Neil H Hyman; Michele A Rubin; Sushila R Dalal; Atsushi Sakuraba; Joel Pekow; Eugene B Chang; David T Rubin Journal: Inflamm Bowel Dis Date: 2022-09-01 Impact factor: 7.290